Presenters focus on empowering patients to effectively navigate the health care system. Topics include debunking common myths, utilizing practical tools, and understanding the differences between alternative, complementary, and integrative medicine.
Panelists highlight the perspectives of providers and people living with hepatitis B regarding strategies to assess and address patient-reported outcomes, and cultivate shared decision-making that is informed by scientific evidence, provider expertise, and patient preferences. The diverse panel includes representatives of nonprofit organizations, health systems, academic institutions, and patient advocacy groups. A question-and-answer period follows speaker presentations.
CDC's Division of Viral Hepatitis Director Carolyn Wester will discuss the on-going work at DVH and the division's role in the White House Hepatitis C Elimination plan.
This session will highlight evolving approaches to second-line treatment in Primary Biliary Cholangitis (PBC) through a case-based discussion. It will provide practical insights and foster a dynamic exchange between leading hepatologists.
Industry Supporter: Ipsen
Our newest survey highlights what many already know: managing SLD isn’t just about liver health. Barriers like transportation, finances, isolation, and mental health challenges play a big role in how people experience their condition. Join us for an honest, community conversation about these realities, and hear about programs and resources designed to help you take care of both your health and your well-being.
Zoom: https://us02web.zoom.us/webinar/register/WN_bPc7LXWuQcuhltX1HFZ1zw
"Sober" can mean more than life without alcohol—it can also mean approaching life with clarity, balance, and thoughtful awareness. This conversation explores the many meanings of sobriety—clarity, calm, and conscious living—and how those qualities help us navigate a world that feels increasingly loud and unsettled. Together, we’ll talk about what’s within our control, what’s not, and how to stay steady, compassionate, and connected without diving into divisive topics—focusing instead on how the world around us shapes our inner resilience.
Zoom: https://us02web.zoom.us/meeting/register/s49_sh31TWOuhSOUQR7Iug
This program is designed to explore the recent FDA announcement and HEPATOLOGY publication regarding the role of non-invasive tests (NITs) in MASH clinical trials. The session will review the regulatory perspectives, scientific evidence, and clinical implications of these developments. It will also provide a forum for open dialogue and audience engagement, highlighting both opportunities and challenges for integrating NITs into practice and research. Attendees will leave with a clearer understanding of how these updates may shape the future landscape of hepatology and drug development.
Stigma surrounding liver disease impacts patient outcomes, mental health, and access to care. Presenters explore the roots of stigma, with a focus on how misconceptions about liver disease affect care delivery and perpetuate health inequities. Special attention is given to the unique challenges faced by LGBTQ+ patients, who often encounter additional layers of bias and discrimination. The goal of this session is to empower health care clinicians, advocates, and stakeholders to foster equity and empathy in liver care for all communities by recognizing the impact of stigma on patient outcomes; developing inclusive practices for stigma-free care; and advocating for systemic change.
This joint AASLD and the Taiwan Association for the Study of the Liver (TASL) session aims to: (1) continue the collaborative relationship between TASL and AASLD; (2) share experiences and contributions to HCC surveillance in Taiwan with AASLD members; (3) facilitate young investigators' communication with AASLD members to foster future collaboration; and (4) encourage TASL members to attend The Liver Meeting to learn from and connect with scholars from around the world.
Join members of the Liver Leaders Council in the Patient Lounge for a meet and greet to learn more about Clinical Trials.